Milestone Announcement: Dr. Everett McCorvey Named Inaugural Principal Guest Conductor at Opera Columbus
Dr. McCorvey's illustrious career as a conductor, educator, and performer has already left an indelible mark on opera. He is the founder and music director of the American Spiritual Ensemble, the director and executive producer of the University of Kentucky Opera Theatre, president of Global Creative Connections, a production and management company for musical and theatrical events, and the artistic director of the National Chorale. His dedication to musical excellence and commitment to fostering a vibrant and inclusive arts community align seamlessly with Opera Columbus's vision for the future. In this groundbreaking role, Dr. McCorvey will not only wield the conductor's baton but will serve as a artistic partner, collaborating closely with Opera Columbus's leadership, including the General Director and CEO.
"I am truly excited to embark on this artistic journey with Opera Columbus, a company known for its unwavering commitment to innovation and creativity," said Dr. McCorvey. "The prospect of contributing to such a dynamic and forward-thinking institution is invigorating.”
Most recently with Opera Columbus, Dr. McCorvey has judged the Cooper-Bing Vocal Competition and conducted Carmen, which was recently named best opera production of the year by BroadwayWorld. In his new position, Dr. McCorvey will lead one opera each season, work closely with the Crane Directing Fellow, and actively participate in various engagement programming and events throughout the Central Ohio community.
"We are thrilled and honored to welcome the exceptional Dr. Everett McCorvey to the Opera Columbus family. His extraordinary talent will undoubtedly enrich our artistic endeavors, and we eagerly anticipate the harmonious collaboration that lies ahead,” said Julia Noulin-Mérat, General Director + CEO of Opera Columbus. “Dr. McCorvey's appointment marks a significant milestone in our commitment to musical excellence and innovation, and we are poised for a transformative era."
Dr. McCorvey will begin a three-year engagement with the Columbus company in February 2024.